160 related articles for article (PubMed ID: 37855394)
21. Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B
Gurbel PA; Bliden KP; Tantry US
J Thromb Thrombolysis; 2021 Feb; 51(2):260-264. PubMed ID: 33170486
[TBL] [Abstract][Full Text] [Related]
22. Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action.
Patrignani P; Tacconelli S; Contursi A; Piazuelo E; Bruno A; Nobili S; Mazzei M; Milillo C; Hofling U; Hijos-Mallada G; Sostres C; Lanas A
Front Pharmacol; 2024; 15():1362217. PubMed ID: 38495101
[No Abstract] [Full Text] [Related]
23. Urinary 11-Dehydro-Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study.
Szczeklik W; Stodółkiewicz E; Rzeszutko M; Tomala M; Chrustowicz A; Żmudka K; Sanak M
J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27481134
[TBL] [Abstract][Full Text] [Related]
24. In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.
Davi G; Alessandrini P; Mezzetti A; Minotti G; Bucciarelli T; Costantini F; Cipollone F; Bon GB; Ciabattoni G; Patrono C
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3230-5. PubMed ID: 9409316
[TBL] [Abstract][Full Text] [Related]
25. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo.
Landolfi R; Ciabattoni G; Patrignani P; Castellana MA; Pogliani E; Bizzi B; Patrono C
Blood; 1992 Oct; 80(8):1965-71. PubMed ID: 1327286
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs.
Reilly IA; FitzGerald GA
Blood; 1987 Jan; 69(1):180-6. PubMed ID: 3790723
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation.
Davì G; Neri M; Falco A; Festi D; Taraborelli T; Ciabattoni G; Basili S; Cuccurullo F; Patrono C
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):246-51. PubMed ID: 15472127
[TBL] [Abstract][Full Text] [Related]
28. Reduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor.
Ikonomidis I; Andreotti F; Nihoyannopoulos P
Heart; 2004 Apr; 90(4):389-93. PubMed ID: 15020512
[TBL] [Abstract][Full Text] [Related]
29. Paired analysis of urinary thromboxane B2 metabolites in humans.
Catella F; FitzGerald GA
Thromb Res; 1987 Sep; 47(6):647-56. PubMed ID: 3686481
[TBL] [Abstract][Full Text] [Related]
30. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
[TBL] [Abstract][Full Text] [Related]
31. Urinary Thromboxane B2 and Lethal Prostate Cancer in African American Men.
Kiely M; Milne GL; Minas TZ; Dorsey TH; Tang W; Smith CJ; Baker F; Loffredo CA; Yates C; Cook MB; Ambs S
J Natl Cancer Inst; 2022 Jan; 114(1):123-129. PubMed ID: 34264335
[TBL] [Abstract][Full Text] [Related]
32. Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man.
Ciabattoni G; Pugliese F; Davi G; Pierucci A; Simonetti BM; Patrono C
Biochim Biophys Acta; 1989 Jul; 992(1):66-70. PubMed ID: 2752040
[TBL] [Abstract][Full Text] [Related]
33. Aspirin response: Differences in serum thromboxane B2 levels between clinical studies.
Brun C; Daali Y; Combescure C; Zufferey A; Michelson AD; Fontana P; Reny JL; Frelinger AL
Platelets; 2016; 27(3):196-202. PubMed ID: 26270593
[TBL] [Abstract][Full Text] [Related]
34. Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A
Mitchell JA; Knowles RB; Kirkby NS; Reed DM; Edin ML; White WE; Chan MV; Longhurst H; Yaqoob MM; Milne GL; Zeldin DC; Warner TD
Circ Res; 2018 Feb; 122(4):555-559. PubMed ID: 29298774
[TBL] [Abstract][Full Text] [Related]
35. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD
Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients.
Lanas A; Tacconelli S; Contursi A; Piazuelo E; Bruno A; Ronci M; Marcone S; Dovizio M; Sopeña F; Falcone L; Milillo C; Mucci M; Ballerini P; Patrignani P
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173923
[TBL] [Abstract][Full Text] [Related]
37. 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.
Catella F; Healy D; Lawson JA; FitzGerald GA
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5861-5. PubMed ID: 3461463
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia.
Cangemi R; Carnevale R; Nocella C; Calvieri C; Cammisotto V; Novo M; Castellani V; D'Amico A; Zerbinati C; Stefanini L; Violi F;
Pharmacol Res; 2018 May; 131():66-74. PubMed ID: 29577968
[TBL] [Abstract][Full Text] [Related]
39. Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A
McCarthy NS; Vangjeli C; Surendran P; Treumann A; Rooney C; Ho E; Sever P; Thom S; Hughes AD; Munroe PB; Howard P; Johnson T; Caulfield M; Shields DC; O'Brien E; Fitzgerald DJ; Stanton AV
Atherosclerosis; 2018 Feb; 269():42-49. PubMed ID: 29258006
[TBL] [Abstract][Full Text] [Related]
40. Estimated rate of thromboxane secretion into the circulation of normal humans.
Patrono C; Ciabattoni G; Pugliese F; Pierucci A; Blair IA; FitzGerald GA
J Clin Invest; 1986 Feb; 77(2):590-4. PubMed ID: 3944270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
